PUBLISHER: TechSci Research | PRODUCT CODE: 1255231
PUBLISHER: TechSci Research | PRODUCT CODE: 1255231
Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Type, By Route of Administration, By End User, By Region and Competition
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global penicillin market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the high prevalence of infectious diseases such as lower respiratory infections, malaria, and tuberculosis, among others. In 2020, Africa had the highest prevalence of tuberculosis incidence per 100 000 population. The incidence rate was about 220. Similarly, the Americas reported some 29 new cases of tuberculosis per 100,000 inhabitants. Additionally, growing initiatives and investments by government organizations and pharmaceutical & biotechnology companies across the globe for developing novel antibiotics have significantly increased the demand for penicillin worldwide. Additionally, the growing adoption of new drugs in the healthcare sector has significantly increased, thereby supporting the growth of global penicillin market. Besides, increasing awareness about novel treatments will further increase the demand for penicillin in the coming years, thereby supporting market growth.
Growing Prevalence of Various Types of Infections
Every day the frequency of bacterial infections is increasing. The main reason for increasing bacterial infection is not maintaining proper health, not washing hands before eating or cooking, sneezing without covering, and poor sanitation and hygiene practices. This has significantly increased the demand for antibiotics, thereby creating lucrative growth opportunities for the penicillin market during the forecast period. In 2021, the daily defined dose of antibiotics consumption in Italy was around 13 per 1,000 inhabitants. Similarly, in low and middle-income countries, public transport is the main source of communication, and most of the spread of bacterial infections is being witnessed due to the use of public transport, thereby increasing the demand for antibiotics and creating opportunities for the growth of the penicillin market.
Expanding Research & Development Activities
The growing incidence of antibiotic resistance in bacteria and the increasing prevalence of various communicable bacterial infections have made biotechnology and pharmaceutical companies focus on developing new and advanced therapies and products. This, in turn, is expected to create new prospects for the growth of the penicillin market. According to clinicaltrials.gov, there are around 93 clinical trials related to penicillin that are under different phases. Similarly, betterment in the new drug approval process is expected to boost market growth over the years. In 2020, Merck received an acceptance for a review of a supplemental new drug application from the U.S. FDA for RECARBRIO intended for HABP/VABP. The growing burden of infectious diseases is compelling government and non-government organizations to invest in research and development activities that will further boost the development of novel antibiotics and create new policies for the development of new drugs.
Market Segmentation
The global penicillin market can be segmented by product, type, route of administration, end-user, and by region. Based on the product, the market can be divided into Bulk and Dosage. Based on type, the market can be segmented into Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, and Others. Based on the route of administration, the market can be differentiated into Oral, Intramuscular, and Intravenous. Based on end users, the market can be grouped into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global penicillin market on account of the increasing prevalence of infectious in the country. According to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases is around 7.2 million.
Recent Developments
- In August 2022, PAION AG launched XERAVA (eravacycline), in Germany, for the treatment of complicated intra-abdominal infections (cIAI) in adults.
- In October 2021, the Cephalosporin antibiotics branch of GSK was purchased by Novartis. It is currently the exclusive owner of three well-known brands in more than 100 markets, establishing its position as the top manufacturer of antibiotics across the globe.
Market Players
Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc. are some of the leading players operating in the Global Penicillin Market.
Report Scope
In this report, global penicillin market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Penicillin Market, By Product:
- Bulk
- Dosage
Penicillin Market, By Type:
- Aminopenicillin
- Antipseudomonal Penicillin
- Beta Lactamase Inhibitor
- Others
Penicillin Market, By Route of Administration:
- Oral
- Intramuscular
- Intravenous
Penicillin Market, By Route of End User:
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
Penicillin Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
- 5.1. Ongoing Clinical Trials
- 5.2. Completed Clinical Trials
- 5.3. Terminated Clinical Trials
- 5.4. Breakdown of Pipeline, By Development Phase
- 5.5. Breakdown of Pipeline, By Status
- 5.6. Breakdown of Pipeline, By Study Type
- 5.7. Breakdown of Pipeline, By Region
- 5.8. Clinical Trials Heat Map
6. Global Penicillin Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value & Volume
- 6.2. Market Share & Forecast
- 6.2.1. By Product (Bulk, Dosage)
- 6.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
- 6.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
- 6.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
- 6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 6.2.6. By Company (2022)
- 6.3. Market Map
- 6.3.1. By Product
- 6.3.2. By Application
- 6.3.3. By Technique
- 6.3.4. By Source
- 6.3.5. By Region
7. North America Penicillin Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value & Volume
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By Route of Administration
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Penicillin Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value & Volume
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Type
- 7.3.1.2.3. By Route of Administration
- 7.3.1.2.4. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Canada Penicillin Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value & Volume
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Type
- 7.3.2.2.3. By Route of Administration
- 7.3.2.2.4. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Mexico Penicillin Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value & Volume
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Type
- 7.3.3.2.3. By Route of Administration
- 7.3.3.2.4. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.1. United States Penicillin Market Outlook
8. Europe Penicillin Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value & Volume
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Route of Administration
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Penicillin Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value & Volume
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Type
- 8.3.1.2.3. By Route of Administration
- 8.3.1.2.4. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. Germany Penicillin Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value & Volume
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Type
- 8.3.2.2.3. By Route of Administration
- 8.3.2.2.4. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. United Kingdom Penicillin Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value & Volume
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Type
- 8.3.3.2.3. By Route of Administration
- 8.3.3.2.4. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. Italy Penicillin Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value & Volume
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Type
- 8.3.4.2.3. By Route of Administration
- 8.3.4.2.4. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Spain Penicillin Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value & Volume
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Type
- 8.3.5.2.3. By Route of Administration
- 8.3.5.2.4. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. France Penicillin Market Outlook
9. Asia-Pacific Penicillin Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value & Volume
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Route of Administration
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Penicillin Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value & Volume
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Type
- 9.3.1.2.3. By Route of Administration
- 9.3.1.2.4. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. India Penicillin Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value & Volume
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Type
- 9.3.2.2.3. By Route of Administration
- 9.3.2.2.4. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Japan Penicillin Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value & Volume
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Type
- 9.3.3.2.3. By Route of Administration
- 9.3.3.2.4. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.4. South Korea Penicillin Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value & Volume
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Product
- 9.3.4.2.2. By Type
- 9.3.4.2.3. By Route of Administration
- 9.3.4.2.4. By End User
- 9.3.4.1. Market Size & Forecast
- 9.3.5. Australia Penicillin Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value & Volume
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Product
- 9.3.5.2.2. By Type
- 9.3.5.2.3. By Route of Administration
- 9.3.5.2.4. By End User
- 9.3.5.1. Market Size & Forecast
- 9.3.1. China Penicillin Market Outlook
10. South America Penicillin Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value & Volume
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Type
- 10.2.3. By Route of Administration
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Penicillin Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value & Volume
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Type
- 10.3.1.2.3. By Route of Administration
- 10.3.1.2.4. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Argentina Penicillin Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value & Volume
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Type
- 10.3.2.2.3. By Route of Administration
- 10.3.2.2.4. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Colombia Penicillin Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value & Volume
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Type
- 10.3.3.2.3. By Route of Administration
- 10.3.3.2.4. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Penicillin Market Outlook
11. Middle East and Africa Penicillin Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value & Volume
- 11.2. Market Share & Forecast
- 11.2.1. By Product
- 11.2.2. By Type
- 11.2.3. By Route of Administration
- 11.2.4. By End User
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Penicillin Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value & Volume
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Product
- 11.3.1.2.2. By Type
- 11.3.1.2.3. By Route of Administration
- 11.3.1.2.4. By End User
- 11.3.1.1. Market Size & Forecast
- 11.3.2. Saudi Arabia Penicillin Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value & Volume
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Product
- 11.3.2.2.2. By Type
- 11.3.2.2.3. By Route of Administration
- 11.3.2.2.4. By End User
- 11.3.2.1. Market Size & Forecast
- 11.3.3. UAE Penicillin Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value & Volume
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Product
- 11.3.3.2.2. By Type
- 11.3.3.2.3. By Route of Administration
- 11.3.3.2.4. By End User
- 11.3.3.1. Market Size & Forecast
- 11.3.1. South Africa Penicillin Market Outlook
12. Market Dynamics
- 12.1. Drivers
- 12.1.1. Growing Prevalence of Infectious Diseases
- 12.1.2. Rise in Research & Development Activities
- 12.1.3. Supportive Government Policies & Initiatives
- 12.2. Challenges
- 12.2.1. Development of Antibacterial Resistance
- 12.2.2. Stringent Regulatory Scenario
13. Market Trends & Developments
- 13.1. Recent Developments
- 13.2. Mergers & Acquisitions
- 13.3. Product Launches
14. Global Penicillin Market: SWOT Analysis
15. Competitive Landscape
- 15.1. Business Overview
- 15.2. Product Offerings
- 15.3. Recent Developments
- 15.4. Financials (As Reported)
- 15.5. Key Personnel
- 15.5.1. Astellas Pharma Inc.
- 15.5.2. Novartis International AG
- 15.5.3. GlaxoSmithKline plc
- 15.5.4. Pfizer Inc.
- 15.5.5. Merck Co. & Inc.
- 15.5.6. F.Hoffmann-La Roche Ltd.
- 15.5.7. Toyama Chemical Co., Ltd.
- 15.5.8. Sanofi Aventis SA
- 15.5.9. MiddleBrook Pharmaceuticals, Inc.
- 15.5.10. Gilead Sciences Inc.
16. Strategic Recommendations
